Kinesia as Digital Endpoint
Movement Disorder Clinical Trials
Commercial/ServiceActive
Key Facts
Indication
Movement Disorder Clinical Trials
Phase
Commercial/Service
Status
Active
About Great Lakes NeuroTechnologies
Great Lakes NeuroTechnologies is a private, revenue-generating medical device company specializing in digital biomarkers and remote monitoring for neurological conditions, particularly movement disorders. The company has established a commercial product line, Kinesia, which is used in clinical care, deep brain stimulation (DBS) management, and as an objective endpoint in global clinical trials. Its growth is supported by NIH SBIR grants and a growing patent portfolio covering AI-driven symptom measurement and treatment adjustment, positioning it at the intersection of neurology, telemedicine, and decentralized clinical trials.
View full company profile